Suggested Topics within your search.
Showing 741 - 760 results of 1,973 for search '"antigen"', query time: 0.09s Refine Results
  1. 741

    Immunoregulatory programs in anti‐N‐methyl‐D‐aspartate receptor encephalitis identified by single‐cell multi‐omics analysis by Xinhui Li, Yicong Xu, Weixing Zhang, Zihao Chen, Dongjie Peng, Wenxu Ren, Zhongjie Tang, Huilu Li, Jin Xu, Yaqing Shu

    Published 2025-01-01
    “…In parallel, single‐cell B cell receptor sequencing (scBCR‐seq) and repertoire analysis were conducted to assess antigen‐driven clonal expansion within the B cell population. …”
    Get full text
    Article
  2. 742

    Genetic disruption of Blimp-1 drastically augments the antitumor efficacy of BCMA-targeting CAR T cells by Anthony M. Battram, Joan Mañé-Pujol, David F. Moreno, Aina Oliver-Caldés, Judit Carpio, Oriol Cardus, Luis Gerardo Rodríguez-Lobato, Álvaro Urbano-Ispizua, Carlos Fernández de Larrea

    Published 2025-02-01
    “…Abstract: Chimeric antigen receptor (CAR) T cells directed against B-cell maturation antigen (BCMA) are an effective treatment for multiple myeloma (MM), but short persistence and frequent relapses are challenges for this immunotherapy. …”
    Get full text
    Article
  3. 743

    Carbon Material Hybrid Construction on an Aptasensor for Monitoring Surgical Tumors by Renyuan Ma, Subash C. B. Gopinath, Thangavel Lakshmipriya, Yeng Chen

    Published 2022-01-01
    “…Carcinoembryonic antigen (CEA) is a glycoprotein, one of the common tumor biomarkers, found at low levels in body fluids. …”
    Get full text
    Article
  4. 744

    Establishment of a Rapid and Convenient Fluoroimmunoassay Platform Using Antibodies Against PDL1 and HER2 by Ji Eun Choi, Hanool Yun, Hee-Jin Jeong

    Published 2025-01-01
    “…This robust platform can be readily adapted for various fluoroimmunoassays targeting other antigens of interest.…”
    Get full text
    Article
  5. 745

    Dynamic roles of tumor-infiltrating B lymphocytes in cancer immunotherapy by Shishengnan Song, Chong Wang, Yangchao Chen, Xiaorong Zhou, Yi Han, Haijian Zhang

    Published 2025-02-01
    “…Naive B cells present the initial antigen, germinal center B cell subsets enhance antibody affinity, and immunoglobulin subtypes exert multiple immune effects, while regulatory B cells establish immune tolerance. …”
    Get full text
    Article
  6. 746

    Transverse Myelitis Associated with Cryptococcus neoformans in an Immunocompetent Patient by David B. Villafuerte, Marco F. Passeri, Rayan Qazi, Moulika Baireddy, Fernando L. Sanchez

    Published 2022-01-01
    “…Analysis of cerebral spinal fluid (CSF) obtained via lumbar puncture was positive for the Streptococcus antigen with cultures also growing Cryptococcus neoformans. …”
    Get full text
    Article
  7. 747

    T Cell-Tumor Interaction Directs the Development of Immunotherapies in Head and Neck Cancer by A. E. Albers, L. Strauss, T. Liao, T. K. Hoffmann, A. M. Kaufmann

    Published 2010-01-01
    “…Another important tumor-escape mechanism is to avoid recognition by dysregulation of antigen processing and presentation. Thus, both induction of functional CTL and susceptibility of the tumor and its microenvironment to become T cell targets should be considered in CTL-based immunotherapy.…”
    Get full text
    Article
  8. 748

    Application of Bionanomaterials in Tumor Immune Microenvironment Therapy by Jiawei Wang, Yan Bao, Yandan Yao

    Published 2021-01-01
    “…Immune checkpoint blockade therapy and chimeric antigen receptor T-cell (CAR-T) immunotherapy are clinically effective in a variety of cancers. …”
    Get full text
    Article
  9. 749

    Antibody-Mediated Rejection: Pathogenesis, Prevention, Treatment, and Outcomes by Olivia R. Blume, Sarah E. Yost, Bruce Kaplan

    Published 2012-01-01
    “…It is important to have an understanding of human-leukocyte antigen (HLA) typing including well-designed studies to determine anti-MHC-class-I-related chain A (MICA) and antibody rejection pathogenesis. …”
    Get full text
    Article
  10. 750

    The Effects of TLR Activation on T-Cell Development and Differentiation by Bo Jin, Tao Sun, Xiao-Hong Yu, Ying-Xiang Yang, Anthony E. T. Yeo

    Published 2012-01-01
    “…Invading pathogens have unique molecular signatures that are recognized by Toll-like receptors (TLRs) resulting in either activation of antigen-presenting cells (APCs) and/or costimulation of T cells inducing both innate and adaptive immunity. …”
    Get full text
    Article
  11. 751

    The Metabolic Features of Tumor-Associated Macrophages: Opportunities for Immunotherapy? by Sonja S. Mojsilovic, Slavko Mojsilovic, Victor H. Villar, Juan F. Santibanez

    Published 2021-01-01
    “…Also, new macrophage-based cell therapeutic technologies recently developed using chimeric antigen receptor bioengineering are exposed, which may overcome all solid tumor physical barriers impeding the current adoptive cell therapies and contribute to developing novel cancer immunotherapies.…”
    Get full text
    Article
  12. 752

    Desensitization: Overcoming the Immunologic Barriers to Transplantation by Supreet Sethi, Jua Choi, Mieko Toyoda, Ashley Vo, Alice Peng, Stanley C. Jordan

    Published 2017-01-01
    “…HLA (Human Leucocyte Antigen) sensitization is a significant barrier to successful kidney transplantation. …”
    Get full text
    Article
  13. 753

    Biometallic ions and derivatives: a new direction for cancer immunotherapy by Lin Zhao, Yajun Gui, Jing Cai, Xiangying Deng

    Published 2025-01-01
    “…Biometallic ions (e.g. zinc, copper, magnesium, manganese, etc.) can assist in enhancing the efficacy of immunotherapy through the activation of immune cells, enhancement of tumor antigen presentation, and improvement of the tumor microenvironment. …”
    Get full text
    Article
  14. 754

    Therapeutic implications for the PD-1 axis in cerebrovascular injury by James Feghali, Christopher M. Jackson

    Published 2025-01-01
    “…Classically, PD-L1 on antigen-presenting cells or tissues binds PD-1 on T cell surfaces resulting in T cell inhibition. …”
    Get full text
    Article
  15. 755

    Genetic Contribution to the Pathogenesis of Primary Biliary Cholangitis by Satoru Joshita, Takeji Umemura, Eiji Tanaka, Masao Ota

    Published 2017-01-01
    “…Although the etiology of PBC has not yet been elucidated, human leukocyte antigen (HLA) class II alleles have been consistently associated with disease onset for decades. …”
    Get full text
    Article
  16. 756

    A Patient with Double-Negative VGKC, Peripheral Nerve Hyperexcitability, and Central Nervous System Symptoms: A Postinfectious Autoimmune Disease by Birte Eikeland

    Published 2020-01-01
    “…It is still unknown whether or not there are unidentified extracellular molecular targets within the VGKC-complex, i.e., a novel surface antigen and a pathogenic antibody that can cause affected individuals to develop a peripheral nerve hyperexcitability syndrome. …”
    Get full text
    Article
  17. 757

    Local and Systemic Antibody Responses in Humans with Helicobacter pylori Infection by Thomas G Blanchard, John G Nedrud, Steven J Czinn

    Published 1999-01-01
    “…The most dominant antigen was approximately 66 kDa in molecular mass. …”
    Get full text
    Article
  18. 758

    Superior Sagittal Sinus Thrombosis Complicating Typhoid Fever in a Teenager by P. O. Okunola, G. E. Ofovwe, M. T. Abiodun, C. P. Azunna

    Published 2012-01-01
    “…Urine test for Salmonella typhi Vi antigen was positive, and Widal reaction was significant. …”
    Get full text
    Article
  19. 759

    Bispecific antibodies and CLEM: an analytical approach to advanced cell imaging for therapeutic strategies by Han-ul Kim, Young Kwan Kim

    Published 2025-01-01
    “…Abstract The development of bispecific antibodies (BsAbs) represents a significant advancement in therapeutic antibody design, enabling the simultaneous targeting of two different antigens. This dual-targeting capability enhances therapeutic efficacy, particularly in complex diseases like cancer, where tumor heterogeneity presents a significant challenge for traditional treatments. …”
    Get full text
    Article
  20. 760

    Myeloid-Related Protein Activity in Rheumatoid Arthritis by Charles J. Malemud

    Published 2011-01-01
    “…Engagement of TLRs by the MRP-8/-14 complex may be particularly important for activating antigen-presenting dendritic cells which regulate critical autoimmune responses that promote chronic synovitis characteristic of RA.…”
    Get full text
    Article